Cite
HARVARD Citation
Tauber, R. et al. (n.d.). 831PClinical experience with 100 consecutive patients treated with Lu-177-labeled PSMA-I&T radioligand therapy for metastatic castration-resistant prostate cancer: Final analysis. Annals of oncology. p. . [Online].